Skip to main content
. 2022 Sep 30;55(20):2892–2903. doi: 10.1021/acs.accounts.2c00479

Table 1. Favored Development Strategy As a Function of Atropisomer Interconversion Barrier (ΔG)a.

Interconversion barrier (ΔG; kcal/mol) Isomerization time (1% conversion; 23 °C) Development strategy
<20 (‘Class 1’) <1 s Rapidly equilibrating mixtureb
20–30 (‘Class 2’) 1 s to 9 months Case dependent; disfavored for developmentc
>30 (‘Class 3’) >9 months Single atropisomerd
a

Interconversion barrier classification and development strategies taken from refs (6) and (20).

b

Interconversion rapid versus pharmacological and manufacturing processes.

c

Interconversion on the same time scale as pharmacological and manufacturing processes.

d

Interconversion slow versus pharmacological and manufacturing processes.